These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2302667)

  • 1. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
    Klemi PJ; Joensuu H; Salmi T
    Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor.
    Haba R; Miki H; Kobayashi S; Ohmori M
    Cancer; 1993 Dec; 72(11):3258-62. PubMed ID: 8242551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
    Roush GR; el-Naggar AK; Abdul-Karim FW
    Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors.
    Chadha S; Cornelisse CJ; Schaberg A
    Gynecol Oncol; 1990 Feb; 36(2):240-5. PubMed ID: 2298413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of granulosa tumors.
    Hitchcock CL; Norris HJ; Khalifa MA; Wargotz ES
    Cancer; 1989 Nov; 64(10):2127-32. PubMed ID: 2804901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease.
    Jacoby AF; Young RH; Colvin RB; Flotte TJ; Preffer F; Scully RE; Swymer CM; Bell DA
    Gynecol Oncol; 1992 Jul; 46(1):97-103. PubMed ID: 1634146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients.
    Evans MP; Webb MJ; Gaffey TA; Katzmann JA; Suman VJ; Hu TC
    Cancer; 1995 May; 75(9):2295-8. PubMed ID: 7712440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation.
    Suh KS; Silverberg SG; Rhame JG; Wilkinson DS
    Arch Pathol Lab Med; 1990 May; 114(5):496-501. PubMed ID: 2334259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.
    Bakshi N; Rajwanshi A; Patel F; Ganguly NK
    Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry of ovarian neoplasms.
    Bell DA
    Curr Top Pathol; 1992; 85():337-56. PubMed ID: 1628517
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
    Volm M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.